Medindia LOGIN REGISTER
Medindia
Advertisement

Hormone Therapy may Improve Thinking for Postmenopausal Women

by Chrisy Ngilneii on June 1, 2018 at 3:06 PM
Hormone Therapy may Improve Thinking for Postmenopausal Women

Hormone therapy may slow down cognitive decline among women who have gone through menopause.

Recent study finds that transdermal estradiol in combination with an oral progesterone may improve cognitive function in postmenopausal women.

Advertisement


It comes as no surprise that cognitive function declines as we age. We recognize memory decline in a number of ways, such as not being able to remember a grocery list as easily as we once did. Mild cognitive impairment (MCI) is defined as that intermediate stage between normal aging and dementia. Persons with MCI have an increased risk of progressing to Alzheimer disease or other dementia, with roughly 20 percent of this population crossing over from MCI to a more severe level each year. To date, no pharmacologic treatment has proven effective in managing MCI.

The article "Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial" reviews the results from a recent Korean study regarding the effect of hormone therapy on cognitive function. The study followed postmenopausal women who were diagnosed with MCI and taking donepezil over a 24-month period and showed that cognitive test scores for the women who received hormone therapy significantly increased during that time. Although the study group was small, the study offers promising results, demonstrating that the combination of transdermal estradiol and an oral progesterone can slow down cognitive decline. This is the first known study to evaluate the effect of hormone therapy on MCI.
Advertisement

"This encouraging, small pilot trial suggests a possible benefit of hormone therapy when given to women diagnosed with MCI who are also taking donepezil, a cholinesterase inhibitor," says Dr. JoAnn Pinkerton, executive director of NAMS. "Higher global cognition was seen in two of the three key evaluation criteria in those women using estradiol gel plus an oral micronized progesterone compared with those in the placebo group. Larger trials are needed to evaluate the effect of hormone therapy use before the full onset of Alzheimer disease."

The study is published in Menopause, the journal of The North American Menopause Society (NAMS).

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Latest Women Health News

AI Tool Precisely Detects Postpartum Hemorrhage
An AI tool called Flan-T5 identified postpartum hemorrhage with 95% precision and detected 47% patients with the condition.
Active Scrutiny of Cervical Lesions Fuels Long-Term Cervical Cancer Risk
Active surveillance of cervical lesions was associated with higher cervical cancer risk in the long term compared to its removal.
Contraceptive Pills To Go Over-the-Counter Sale in Japan
Japan initiated the trial of selling morning-after contraceptive tablets over-the-counter in an effort to lower abortion rates and solace for rape victims.
Urinary Tract Infections Surge in Indian Women Due to Ignorance
The rising number of urinary tract infections (UTIs) among Indian women can be attributed primarily to social stigma and a lack of awareness.
Auto-Immune Disease of Pregnancy Linked to Fetal Heart Disorders
Pregnant women with Sjogren's or lupus syndrome have elevated anti-Ro/SSA antibodies which are linked to fetal atrioventricular block in the heart.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Hormone Therapy may Improve Thinking for Postmenopausal Women Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests